WHY LIBERUM HEALTH?
In many areas of healthcare women experience poorer outcomes. At Liberum Health we understand that women’s healthcare needs to be prioritised by addressing the gender health gap and bringing women’s health issues to the forefront.
HEALTHCARE SYSTEMS HAVE RELIED TOO HEAVILY ON A ONE SIZE FITS ALL APPROACH, NOT TAKING CONSIDERATION OF GENDER DIFFERENCES.
Historically, women have been underrepresented in clinical trials and research has placed greater emphasis on male response to medical treatment. This has led to missed opportunities in providing tailored treatment for women.
OUR STORY
Message from our Co-founder Karolina
The disruption in healthcare provision due to the COVID 19 pandemic had a longstanding impact on many medical treatments with appointments and surgeries postponed. As an NHS consultant, I was working from home, juggling looking after young children whilst at the same time trying to provide solutions for my patient’s needs. I was tasked with managing patients remotely, where I experienced first-hand how we were failing to address the unmet needs of women with chronic health conditions.
I felt compelled to provide a higher standard of care and through my own special interest in endometriosis and pelvic pain how to realise this in real terms, by developing novel therapeutics and approach to management.
I met Amelia through a mutual friend and it soon became apparent that our views were aligned. Frustrated by the lack of innovation, specifically surrounding area of women’s health often considered taboo, we set about creating Liberum Health to help bridge the gender health gap.
OUR VISION…
is to develop a range of innovative products to provide smart solutions for managing women’s health conditions that are often overlooked and under researched. We believe in putting women’s needs at the core of product development.
OUR MISION…
is to revolutionise health care for women suffering with chronic conditions and to transform their quality of life, providing life changing solutions.
MEET THE TEAM
CEO
AMELIA SEIFALIAN
Amelia is a qualified doctor working in the NHS. She graduated from UCL medical school where she also completed an integrated BSc in Global Health. Her passions align with Global Health and Women’s Health and emerging treatment strategies. She has published several papers in the field of Global Health, Nanotechnology and Material Sciences, including a paper in The Lancet. She is currently working on a PhD in pelvic mesh for the treatment of pelvic organ prolapse at Imperial College, London and has recently been awarded the Young Innovator’s Award from Innovate UK.
COO
Ulla Haaning Singapuri
Ulla has a background spanning over 20 years in consumer marketing. She held senior commercial and management positions in international companies such as The Coca-Cola Company & Diageo. In addition, she was in global product strategy in Jabra. In recent years, she gained business development experience in the unlicensed/compassionate-use, medicines area. Her extensive international experience in navigating commercial and regulatory challenges; coupled with the exposure to unlicensed medicines have given Ulla a solid foundation to help Liberum Health reach important milestones for future success.
CFO
HANA SALUSSOLIA
Hana worked in financial services for over 15 years and held senior positions in leading global investment banks. Her last banking role was Managing Director at Goldman Sachs. Hana has worked in Biotech for the past 5 years. She is also Founder and Treasurer of charity Microtia, where she played an integral part in helping to change NICE (NHS) guidelines for treatment of those with Microtia. Hana has been philanthropist for over 20 years, helping to secure funding for variety of projects and institutions including GOSH, UCL & The Royal Free.
DOCTOR & RESEARCHER
EMMA ORESKOVIC
Emma received her Medical Degree from University of Zagreb Medical School where she focused on pluripotent stem cells for regenerative applications. Emma is enthusiastic about women’s healthcare and worked on improving healthcare access to women across Benin, West Africa. She is currently completing her Master’s in Nanotechnology and Regenerative Medicine at University College London, where she is working with gold nanoparticles to develop a “pro- regenerative” cornea that is resistant to aging by-products that lead to blindness.
MEDICAL ADVISOR
KAROLINA AFORS
Karolina, one of the co-founders of Liberum Health and one of the co-inventors of Liberum Health Patent, is a London based Consultant Gynaecologist, with a special interest in minimal access gynaecological surgery. She has a strong track record in research and has published extensively within the field of endometriosis and pelvic pain. She is passionate about tech innovation in the health and wellbeing space and advises startups on developing innovative care platforms, with a focus on women’s health.
RESEARCH SCIENTIST
ALENA VDOVCHENKO
Alena, one of the co-inventors of Liberum Health patent, graduated from St. Petersburg State University, where she received a Master’s and Bachelor’s degree in Chemistry with the specialisation in Medical and Material Science. She is currently completing her PhD at Queen Mary University of London, working on the development of drug delivery systems for the treatment of brain disorders. The results of the collaborative work were published in scientific journals in the field of Nanotechnology, Material and Polymer Chemistry.
SCIENTIFIC ADVISOR
RAJVINDER KHASRIYA
Rajvinder is a Consultant in Urogynaecology at the Whittington Hospital and UCLH and lead for the Lower Urinary Tract Symptoms Service. Rajvinder completed her undergraduate studies at University College London (UCL) and she went on to complete a PhD at UCL in 2011. Her clinical research interests lie in chronic UTI; diagnostic methods, pathophysiology and treatment. Her current focus of research is looking at causation of UTI, understanding antimicrobial resistance and the development of new treatment strategies.
SCIENTIFIC ADVISOR
PROF. ALEXANDER SEIFALIAN
Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a year at Harvard Medical School working on development of vascular compliance graft and at Johns Hopkins Medical School looking at the treatment of liver cancer. He published more than 687 peer-reviewed research papers and registered…